1. Home
  2. ASMB vs CHMI Comparison

ASMB vs CHMI Comparison

Compare ASMB & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • CHMI
  • Stock Information
  • Founded
  • ASMB 2005
  • CHMI 2012
  • Country
  • ASMB United States
  • CHMI United States
  • Employees
  • ASMB N/A
  • CHMI N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • CHMI Real Estate Investment Trusts
  • Sector
  • ASMB Health Care
  • CHMI Real Estate
  • Exchange
  • ASMB Nasdaq
  • CHMI Nasdaq
  • Market Cap
  • ASMB 84.5M
  • CHMI 92.0M
  • IPO Year
  • ASMB 2010
  • CHMI 2013
  • Fundamental
  • Price
  • ASMB $13.30
  • CHMI $3.40
  • Analyst Decision
  • ASMB Buy
  • CHMI Buy
  • Analyst Count
  • ASMB 2
  • CHMI 3
  • Target Price
  • ASMB $35.00
  • CHMI $5.00
  • AVG Volume (30 Days)
  • ASMB 22.6K
  • CHMI 253.6K
  • Earning Date
  • ASMB 03-27-2025
  • CHMI 03-06-2025
  • Dividend Yield
  • ASMB N/A
  • CHMI 17.67%
  • EPS Growth
  • ASMB N/A
  • CHMI N/A
  • EPS
  • ASMB N/A
  • CHMI N/A
  • Revenue
  • ASMB $28,326,000.00
  • CHMI N/A
  • Revenue This Year
  • ASMB $282.16
  • CHMI N/A
  • Revenue Next Year
  • ASMB N/A
  • CHMI $27.78
  • P/E Ratio
  • ASMB N/A
  • CHMI N/A
  • Revenue Growth
  • ASMB N/A
  • CHMI N/A
  • 52 Week Low
  • ASMB $11.01
  • CHMI $2.50
  • 52 Week High
  • ASMB $19.93
  • CHMI $3.99
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 38.89
  • CHMI 68.80
  • Support Level
  • ASMB $13.13
  • CHMI $3.07
  • Resistance Level
  • ASMB $14.25
  • CHMI $3.52
  • Average True Range (ATR)
  • ASMB 0.55
  • CHMI 0.10
  • MACD
  • ASMB -0.07
  • CHMI 0.02
  • Stochastic Oscillator
  • ASMB 15.38
  • CHMI 74.54

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

Share on Social Networks: